Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Argan (AGX) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Argan (AGX) over the last 17 years, with Q4 2025 value amounting to $53.7 million.

  • Argan's Non-Current Assets rose 381.84% to $53.7 million in Q4 2025 from the same period last year, while for Oct 2025 it was $216.6 million, marking a year-over-year increase of 594.11%. This contributed to the annual value of $54.9 million for FY2025, which is 759.45% up from last year.
  • Argan's Non-Current Assets amounted to $53.7 million in Q4 2025, which was up 381.84% from $53.9 million recorded in Q3 2025.
  • Over the past 5 years, Argan's Non-Current Assets peaked at $58.9 million during Q2 2021, and registered a low of $44.9 million during Q3 2022.
  • Over the past 5 years, Argan's median Non-Current Assets value was $51.3 million (recorded in 2024), while the average stood at $51.4 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first plummeted by 2328.09% in 2022, then surged by 1269.92% in 2023.
  • Over the past 5 years, Argan's Non-Current Assets (Quarter) stood at $53.4 million in 2021, then fell by 14.03% to $45.9 million in 2022, then rose by 7.93% to $49.6 million in 2023, then grew by 4.32% to $51.7 million in 2024, then increased by 3.82% to $53.7 million in 2025.
  • Its Non-Current Assets stands at $53.7 million for Q4 2025, versus $53.9 million for Q3 2025 and $54.1 million for Q2 2025.